Senarai ini adalah analisis berdasarkan peristiwa pasaran terkini. Ia bukan cadangan pelaburan.
Perihal
Vectura Group plc engages in the design, development, and supply of pharmaceutical products related to inhalation. Its products include flutiform, flutiform K-haler, Ultibro Breezhaler, Seebri Breezhaler, Enerzair Breezhaler, AirFluSal Forspiro, Airbufo Forspiro, Fluticasone Propionate and Salmeterol, Incruse Ellipta, Anoro Ellipta, Trelegy Ellipta, Relvar/Breo Ellipta, and Breelib. The company also provides formulation, process development and tech transfer, pharmaceutical analysis, product manufacturing, and device platforms services, as well as regulatory affairs, device vigilance, and pharmacovigilance services. In addition, it is developing VR315 (US), a generic Advair. Further, the company offers dry powder and pressurized metered dose inhalers, as well as vibrating mesh and jet nebulizers. Vectura Group plc was incorporated in 1997 and is based in Chippenham, the United Kingdom.
Show more...
CEO
Mr. William Downie
Pekerja
502
Negara
UK
Penyenaraian
0 Comments
Kongsi pendapat anda
FAQ
Berapakah harga saham Vectura hari ini?▼
Harga semasa VEC.LSE ialah GBX164.8 GBX — telah meningkat sebanyak +0% dalam 24 jam yang lalu. Pantau prestasi harga saham Vectura dengan lebih dekat pada carta.
Apakah simbol saham Vectura?▼
Bergantung pada bursa, simbol saham mungkin berbeza. Sebagai contoh, di bursa , saham Vectura didagangkan di bawah simbol VEC.LSE.
Adakah Vectura membayar dividen?▼
Ya, dividen VEC.LSE dibayar ms. Dividen terakhir bagi setiap saham ialah 0.19 GBX. Setakat hari ini, Hasil Dividen (FWD)% ialah 11.53%.
Berapa ramai pekerja yang dimiliki oleh Vectura?▼
Sehingga April 07, 2026, syarikat mempunyai 502 pekerja.
Vectura terletak dalam sektor apa?▼
Vectura beroperasi dalam sektor Healthcare.
Bilakah Vectura menyiapkan split saham?▼
Vectura tidak mempunyai sebarang split baru-baru ini.